Results
Senores Pharmaceuticals Q1FY27 Revenue Up 36% YoY
Q1FY27 revenue grew 36% YoY to ₹180.2 Cr with EBITDA surging 87% and margin expanding 810 bps to 29.8%.
Regulated markets drove 71% of revenue, growing 42% YoY, while emerging markets grew 30% YoY.
Ow
